http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008069844-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bef394c70f5664a3057151901caa1f56
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-541
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55544
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55516
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02F2203-69
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02F1-1309
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39
filingDate 2005-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9009031fc731cbb90a08cbc4e5ab25c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b4bebaa4888cf76685ea125ee554ec1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84119a4feafb70c25b786b8cbba8d2b0
publicationDate 2008-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2008069844-A1
titleOfInvention Mucosal Vaccine Adjuvants Containing Bacterial Flagellins as an Active Component
abstract The present invention relates to mucosal vaccine adjuvants containing flagellins, the structural component of flagella, originated from Vibrio vulnificus, Salmonella typhimurium, and Listeria monocytogenes as an active component.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022216734-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110312524-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013072518-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013236496-A1
priorityDate 2004-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6249
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6032
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406705
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395099
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87248487
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227683864
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227683861
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395685
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16850
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87248485

Total number of triples: 43.